Prev Arrow Stocks

Centene Corporation ($CNC) Stock Forecast: Up 8.6% Today

Morpher AI identified a bullish signal. The stock price may continue to rise based on the momentum of the good news.

What is Centene Corporation?

Centene Corporation (CNC) is a healthcare company that operates physician-led micro-hospitals and is involved in managing medical costs, Medicaid contracts, and ACA marketplace growth.

Why is Centene Corporation going up?

CNC stock is up 8.6% on Dec 11, 2025 17:56

  • CNC stock witnessed a significant bullish trend, which can be attributed to favorable investor sentiment and institutional interest in the company.
  • The increased investments from institutional stakeholders such as Amundi and Norges Bank, coupled with optimistic analyst forecasts, drove the upward trajectory of CNC stock.
  • Despite potential risks like reimbursement uncertainties and regulatory challenges, the market primarily focused on Centene Corporation's growth potential and strategic investments, fueling the bullish market sentiment.
  • While the sale of company shares by a director may have sparked some concerns, overall market dynamics appeared to be more influenced by positive investment trends and Centene Corporation's growth prospects.

CNC Price Chart

CNC Technical Analysis

CNC News

Nutex Health’s Micro-Hospitals Deliver Outsized Returns And Growth

Nutex Health, a company operating physician-led micro-hospitals, has shown significant growth and outsized returns, with shares soaring 439.5% over the past year. Its success is attributed to its unique model, strong arbitration wins (over 85% of IDR claims), and rapid expansion. Despite trading at a steep discount, the company faces risks related to reimbursement uncertainty, regulatory compliance, and market volatility.

https://finimize.com/content/nutx-asset-snapshot

0 News Article Image Nutex Health’s Micro-Hospitals Deliver Outsized Returns And Growth

CNC Stock Price Prediction 2026, 2027 & 2030: Analyst Targets & Quantum Computing Outlook

This article provides a comprehensive outlook on Centene Corp. (CNC) stock price predictions for 2026, 2027, and 2030, factoring in analyst targets, bullish and bearish cases, and investment considerations. It highlights potential impacts of Medicaid contract losses, ACA marketplace growth, and challenges in managing medical costs on the company's future profitability and stock valuation.

https://www.benzinga.com/money/cnc-stock-price-prediction

1 News Article Image CNC Stock Price Prediction 2026, 2027 & 2030: Analyst Targets & Quantum Computing Outlook

Norges Bank Makes New $32.16 Million Investment in Crane NXT, Co. $CXT

Norges Bank has made a new investment of $32.16 million in Crane NXT, Co. (NYSE:CXT), acquiring 596,709 shares and owning approximately 1.04% of the company. Other institutional investors like Ameriprise, Wellington, and Congress Asset Management also increased their stakes. Analysts currently have a "Hold" rating on CXT with an average price target of $74.25.

https://www.marketbeat.com/instant-alerts/filing-norges-bank-makes-new-3216-million-investment-in-crane-nxt-co-cxt-2025-12-08/

2 News Article Image Norges Bank Makes New $32.16 Million Investment in Crane NXT, Co. $CXT

Centene Corporation $CNC Shares Acquired by Amundi

Amundi has increased its stake in Centene Corporation (NYSE:CNC) by 6.2% during the 2nd quarter, now owning 3,384,752 shares valued at $183,724,000. Several other hedge funds also adjusted their positions in Centene, and institutional investors and hedge funds collectively own 93.63% of the stock. Analyst ratings for Centene are mixed, with a consensus "Hold" rating and an average price target of $40.00.

https://www.marketbeat.com/instant-alerts/filing-centene-corporation-cnc-shares-acquired-by-amundi-2025-12-07/

3 News Article Image  Centene Corporation $CNC Shares Acquired by Amundi

CENTENE CORP Director Kenneth A Burdick Sells Shares

Kenneth A Burdick, a Director and 10% owner of CENTENE CORP (CNC), sold a total of 66,007 shares of Common Stock on December 3 and 4, 2025 for $2,575,601. The sales occurred at weighted average prices of $39.04 and $39.00. Following these transactions, Burdick directly owns 272,364 shares and indirectly owns 86,498 shares through Burdick Family LLC.

https://www.tradingview.com/news/tradingview:381297b0d2abf:0-centene-corp-director-kenneth-a-burdick-sells-shares/

4 News Article Image CENTENE CORP Director Kenneth A Burdick Sells Shares

Centene Corporation Price History

15.07.2025 - CNC Stock was up 5.0%

  • The uptick in CNC's stock price may be tied to the optimistic views on membership expansion, which could drive revenue growth and operational efficiency.
  • Despite legal hurdles like securities fraud lawsuits, investors appear hopeful about Centene's ability to overcome these challenges and sustain its growth.
  • The market response possibly reflects confidence in Centene's resilience amid legal issues, without explicitly mentioning any ongoing legal actions or inquiries.
  • Investors seem to be placing emphasis on Centene's core business strengths and growth potential, showing a positive market sentiment despite legal uncertainties.

30.09.2025 - CNC Stock was down 5.0%

  • The market potentially anticipated stronger earnings and revenue growth, prompting a sell-off post the earnings beat.
  • Worries surrounding escalating medical expenses and declining Medicaid memberships might have outweighed the upbeat earnings, triggering a bearish response from investors.
  • Traders could have opted for profit-taking after the stock's rise post the positive 2025 forecast, influencing today's bearish trend.

13.07.2025 - CNC Stock was up 5.0%

  • Despite challenges such as class action lawsuits and shareholder investigations, Centene's stock demonstrated a bullish trend, showcasing resilience against legal uncertainties.
  • The market sentiment appears to view the legal obstacles as temporary, resulting in enhanced investor confidence and a favorable stock performance.
  • Investors are seemingly more focused on Centene's operational capabilities and growth potential in the healthcare sector rather than deterred by highlighted legal issues.
  • The contrasting stock performance between Centene's bullish movement and Elevance Health's YTD decline indicates investor favor towards Centene's performance despite legal concerns.

11.11.2025 - CNC Stock was up 8.6%

  • CNC stock witnessed a significant bullish trend, which can be attributed to favorable investor sentiment and institutional interest in the company.
  • The increased investments from institutional stakeholders such as Amundi and Norges Bank, coupled with optimistic analyst forecasts, drove the upward trajectory of CNC stock.
  • Despite potential risks like reimbursement uncertainties and regulatory challenges, the market primarily focused on Centene Corporation's growth potential and strategic investments, fueling the bullish market sentiment.
  • While the sale of company shares by a director may have sparked some concerns, overall market dynamics appeared to be more influenced by positive investment trends and Centene Corporation's growth prospects.

11.11.2025 - CNC Stock was up 5.3%

  • CNC stock price forecasts are considering Medicaid contract losses and ACA marketplace growth. This optimistic outlook may have influenced today's bullish movement.
  • Institutional investors, including Amundi, have been raising their stakes in CNC, showing trust in the company's future performance. This vote of confidence likely improved investor sentiment and contributed to the bullish trend.
  • Despite a Director and 10% owner of CNC selling shares, market sentiment remained positive, focusing on favorable investment activities by other institutions.
  • Reports of increased investments in other healthcare companies like Molina Healthcare, Inc. (MOH) may have had a positive impact on the healthcare sector, potentially driving the bullish movement in CNC.

02.08.2025 - CNC Stock was up 1.6%

  • Despite facing various securities fraud class action lawsuits, Centene Corporation's stock displayed a bullish trend, suggesting investors' confidence in the company's capacity to handle the legal issues.
  • Lawsuits alleging that Centene misrepresented information about its financial risks and business future have not significantly affected the stock price, indicating that investors may be looking more at the company's long-term potential.
  • The approaching deadline for the securities fraud class action lawsuit against Centene does not appear to have discouraged investors, hinting at their belief in the company's ability to address legal issues competently.
  • Today's stock performance by Centene might reflect investors' positive outlook or a perception that the legal challenges will not substantially impact the company's overall performance and financial well-being.

10.09.2025 - CNC Stock was down 5.1%

  • In contrast to the recent optimism surrounding Centene, the stock witnessed a significant downturn today, potentially signaling a change in market conditions.
  • Although the surge in options trading initially boosted investor sentiment, other external factors could have contributed to the sudden drop in stock value.
  • Unforeseen events or market pressures may have played a role in the stock's unexpected performance, deviating from the anticipated bullish trend linked to the surge in options trading.

03.09.2025 - CNC Stock was up 5.1%

  • Options market activity for Centene (NYSE: CNC) shows a strong bullish stance, with many investors opening trades favoring a bullish outlook.
  • The increased bullish sentiment in the options market could reflect growing confidence in Centene's performance and future prospects.
  • This optimistic view from investors in the options market may have impacted the strong bullish movement in Centene's stock price today.

29.09.2025 - CNC Stock was up 12.8%

  • CNC's exceptional Q3 earnings outperformed forecasts, driven by strong premium growth and increasing membership in key sectors, which managed to counterbalance higher medical expenses.
  • The upbeat 2025 projection from Centene bolstered investor trust, resulting in a rise in the stock value.
  • Despite worries surrounding escalating medical expenses and declining Medicaid memberships, Centene's impressive financial results in Q3 provided reassurance to investors about the company's durability.
  • The decline in short interest points to an improved market sentiment towards Centene, with fewer investors taking a pessimistic stance on the stock, contributing to its positive momentum.

23.09.2025 - CNC Stock was down 5.4%

  • Following an announcement from Molina Healthcare regarding their lower-than-expected annual guidance, Centene's stock price decreased.
  • The cautionary statement from Molina Healthcare may have sparked worries among investors regarding the sector's overall performance.
  • This development likely eroded confidence in Centene's future earnings potential, prompting investors to sell their shares.
  • The bearish movement in Centene's stock today is believed to be influenced by the broader impact of Molina Healthcare's guidance on the healthcare insurance industry.

29.09.2025 - CNC Stock was up 12.1%

  • CNC's stock registered a bullish trend today following its stellar Q3 financial performance, exceeding expectations for earnings and revenues.
  • The market reacted positively to CNC's recovery from past difficulties, evident in the notable increase in its stock value.
  • Despite facing challenges in industry costs, CNC demonstrated strong results, showcasing resilience and growth prospects in the healthcare insurance sector.
  • CNC's upward movement was reinforced by a notable drop in short interest, indicating enhanced investor confidence and positivity in the company's outlook.

29.09.2025 - CNC Stock was up 6.1%

  • CNC exceeded Q3 earnings and revenue expectations by a significant margin, showcasing robust financial results.
  • Despite facing challenges in industry costs, CNC demonstrated effective expense management and achieved positive outcomes.
  • The decline in short interest concerning CNC suggests a growing optimistic outlook among investors, contributing to the stock's upward trajectory.
  • Even though CNC initially faced a stock decline along with other healthcare providers following Molina Healthcare's underwhelming guidance, CNC rebounded strongly, likely attributed to its strong financial performance and market positioning.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.